Cite
HARVARD Citation
Kristeleit, R. et al. (2021). Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study. International journal of gynecological cancer. 31 (11), pp. 1428-1436. [Online].